MingMed Biotechnology: MingMed to Present at the 40th Annual J.P. Morgan Healthcare Conference
GUANGZHOU, China, Jan. 5, 2022 /PRNewswire/ -- MingMed Biotechnology, a clinical stage company dedicated to developing First-in-Class pharmaceutical products, today announced that Ms. Liza Ko
Source: finanznachrichten.de